Peter Jüsten, M.Sc., Ph.D. Email & Phone Number

Neuilly-Sur-Seine, Fr

Lausanne Area, Vaud, Switzerland

Neuilly-Sur-Seine, Île-De-France, France

As a member of the Global Consumer Healthcare Science Hub Leadership team, I have worldwide responsibilities for driving consumer-centric & science-based product innovations (OTC drugs, food supplements & medical devices) resulting in sustainable & industry leading growth in Gut Health (including Liver) & Digestive Wellness (Enterogermina containing Probiotics, Dulcolax, Buscopan, No-SPA & Essentiale). In addition, I oversee science based European & Eurasian Product Innovation for all other categories like, e.g., Pain (Doliprane, Novalgin) and Allergy (Allegra, Telfast) • Pipeline development & innovation delivery globally for Digestive Wellness & Gut/Liver Health, and for Europe/Eurasia (all categories). Substantial incremental innovation net sales delivered in 2023. • New product development (formulations, formats, claims & packaging) incl. clinical research based on local consumer & healthcare professional (HCP) insights. Key markets are Europe/Eurasia, Latin-America, & South-East Asia. • Board member of IPA (Global International Probiotic Association with HQ in US) until March 2024• Global Head of the Sanofi CHC cross-category Microbiome science & technology platform (launch of Probiotics)

Gentilly, France

• Driving scientific product innovations incl. clinical development in Nutritionals & Sleep (Pharmaton, Magne, Novanight, Unisom, Cenovis & Nature’s Own). Key markets: Latin-America, Europe/Eurasia, South-East Asia & Australia. • R&D Head of Sanofi CHC cross-category Microbiome science & technology platform (launch of Postbiotic in US)• Set-up of Personalised Nutrition pilot in Australia with potential expansion into China

Marcq-En-Barœul, France And Desio, Lombardia, Italy

Development incl. clinicals/production/sales (B2B) of health/nutritional ingredients incl. formulations (Pro- & Prebiotics, Nutritional Yeasts, Yeast derived Proteins/Peptides/Fibres, S-Adenosyl methionine, Glutathione, Chondroitin, Folates, Vitamin K2, Antibiotics) - derived from fermentation - for Pharma, Supplements, Functional Foods & Pet Care.• GM (incl. complex P&L management) of WW operating BU « Human Care » (43 people) with teams (sales, marketing & R&D/10) in France, US, Brazil, Singapore & China, & one production site in Italy (Omniabios s.r.l.) • Deputy GM (mainly R&D, Operations & Quality) of the Italian company Gnosis s.r.l. with two production sites (Italy & Switzerland) and one R&D centre (30 people). I also lead the integration of acquired Gnosis s.r.l. into Lesaffre through transformation of sites & people.• Healthcare/Wellness strategy definition “2020” incl. innovation pipeline & clinical development and sales & marketing structure for Pharma, Supplements, Functional Foods, Cosmetics, & Pet Care. • Board member of DigestScience (French Foundation dedicated to Digestive Diseases & Nutrition)• Non-permanent member of the investment committee “Microbiome & Nutrition” at Seventure Partners/Paris

Marcq-En-Barœul, Nord-Pas-De-Calais, France

For BU Human Care (see above). Procelys (https://procelys.com) develops, makes and sells (B2B) natural yeast extracts as microbial- and cell-nutrients in culture media in domains like Bio-pharma, Diagnostics, & Food/Feed Bio-ingredients. • Definition/implementation of a 4-year strategy (2014-2017) incl. product pipeline, clinicals & sales force structure.• 2 successful acquisitions incl. technical due diligence for Human Care in Italy, Omniabios in 2013 & Gnosis in 2015

Marcq-En-Barœul, Nord-Pas-De-Calais, France

• Start-up & co-management of the new B2B business « Human Care (see above) » (13 people, T/O: >10 M€ 2012)• Definition/implementation of a general healthcare strategy for natural Supplement & Functional Food ingredients • Development (incl. clinicals) of new natural health ingredients derived from microbial fermentation (bacteria & yeast probiotics, prebiotics, nutritional yeast, fortified/mineral yeasts, yeast extracts/proteins, yeast fibres, & yeast oil).

Issy-Les-Moulineaux, Île-De-France, France

• Restructuring & management of an R&D department (formulations & botanical extracts) of 50 people.• Definition of a new « product formulation » strategy to have cosmetics with more natural/botanical ingredients.

Saint-Fons, Rhône-Alpes, France

• Project Manager to develop new products (health ingredients)/formulations/processes including industrialisation (Europe & China) of analgesics, probiotics & calcium phosphates. • Technol. benchmark, financial/technical risk evaluation/management, and strategic/organisational decision making.• Start-up of a new B2B “formulation service” in Europe & US for producers of generics/OTC drugs & Supplements• Assure technical customer service (sectors Pharmaceuticals/OTC & Nutraceuticals/Food supplements)

Sisseln Ag, Kanton Aargau, Switzerland

• Project manager to develop new products/processes (natural vitamins B2 & C via fermentation for Berocca & Supradyn; natural epigallocatéchine gallate, EGCG, via green tee extraction) for production in Germany/Japan/China • Definition & improvement of mechanical properties & morphologies of solids (natural vitamins B2 & C for Berocca & Supradyn, and EGCG) to improve product formulation performances

Yalding, Kent, United Kingdom

• Coordination of University- and EU funded Projects • Project manager to develop new products/processes (granules, films) including industrialisation (UK & Belgium

Transition To General Management

Phd, Biochemical Engineering & Biotechnology

Dipl.-Ing. (M.Sc.), Biochemical Engineering